Bionote Pre-IPO - The Negatives - Fortunes Generated from a Sole Related Party
Bionote (377740 KS) is looking to raise approximately US$200m in its Korean IPO. The IPO would consist of both a primary and secondary selldown.
295 Views
Bionote Pre-IPO - The Positives - Expanding Product Portfolio and Vertically Integrated
Bionote (377740 KS) is looking to raise approximately US$200m in its Korean IPO. The IPO would consist of both a primary and secondary selldown.
230 Views
BioNote IPO Valuation Analysis
Our base case valuation is target price of 16,182 won per share, which is 10% lower than the low end of the IPO price range.
240 Views
BioNote IPO Preview
BioNote, a Korean company specializing in bio contents and animal diagnostics, is getting ready for an IPO in November. The IPO offering amount is...
211 Views